European officials say the side effects of AstraZeneca’s vaccine should include abnormal blood clotting



The European Medicines Agency (EMA), the regulatory body of the European Union, said vaccine producer AstraZeneca needs to mention rare blood clots as a possible side effect.

Emer Cooke, EMA Secretary-General, said in a media briefing Wednesday that a detailed investigation of the vaccine revealed that “cases of abnormal blood clotting reported after vaccination with the AstraZeneca vaccine were listed as possible side effects of the vaccine. I will. “

The EMA and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) also said that despite the potential side effects, the benefits outweigh the risks.

“The reported combination of blood clots and low platelets is very rare, and the overall benefit of the vaccine in the prevention of COVID-19 outweighs the risk of side effects,” the EMA said in a statement.

“COVID-19 is a very serious illness with high hospitalization and mortality rates, and COVID still causes thousands of deaths across the EU,” Cook said. “This vaccine has proven to be very effective. It prevents serious illness and hospitalization and saves lives.”

European Union drug regulators said Wednesday that there was a “potential link” between the AstraZeneca CCP virus vaccine and “very rare” blood clots, but recommended that vaccination be continued. He emphasized that profits outweigh risks.

The European Medicines Agency (EMA) has been vaccinated with healthcare professionals to continue to recognize the possibility of very rare blood clots combined with low levels of platelets that occur within two weeks of vaccination. Calling people attention. ” Said in a statement Wednesday.

The statement continues as follows: “So far, most of the reported cases have occurred in women under the age of 60 within two weeks of vaccination. No specific risk factors have been identified based on currently available evidence. Hmm.”

The Epoch Times contacted AstraZeneca for comment. Pharmaceutical giants and the World Health Organization (WHO) have previously stated that the study does not increase the risk of blood clots from vaccines.

According to an EMA statement, EMA officials reviewed dozens of cases, primarily from Europe and the United Kingdom. There, about 25 million people were vaccinated with the AstraZeneca vaccine.

Last month, more than 12 European countries, including France, Germany, Italy and Spain, stopped using the AstraZeneca vaccine after reports of blood clots and the deaths of several people who were shot. Most countries have resumed vaccination, but some have suspended elderly vaccinations.

Jack Phillips contributed to this report.

Posted on